Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-19
    E.g., 2018-09-19

Archive Search

2 results
12:00 AM, Oct 24, 2013  |  BC Innovations | Strategy

Synaptic synopsis

Depression GRIN2B (NR2B) Cerecor Inc. CERC-301 Phase I Depression NMDAR Naurex NRX-1074 Phase I Depression mGluR2
GRM2) BrainCells Inc. BCI-838 Phase I Depression AMPA glutamate receptor (GRIA; GLUR) Pfizer Inc. (NYSE:PFE) PF-04958242 …
mGluR5 Seaside Therapeutics Inc. STX110 Preclinical ASD mGluR4 (GRM4) Domain Therapeutics S.A. DT1687 Preclinical Schizophrenia mGluR2
12:00 AM, Oct 13, 2011  |  BC Innovations | Strategy

Lilly's opening moves

cancer metabolism target. Finally, Lilly is screening for allosteric metabotropic glutamate receptor subtype 2 ( mGluR2
GRM2 ) antagonists for neurological or psychiatric indications and calcitonin gene-related peptide receptor ( CGRP …